Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras

Area of Science:

• Immunology
• Autoimmunity
• Cell Biology

Background:

• The lpr mutation in the Fas apoptosis receptor leads to lymphadenopathy and autoantibody production in mice.
• Abnormal T cell accumulation and autoantibody production are linked to lpr-origin cells.
• Normal B cells fail to respond to antigens in lpr hosts, suggesting B cell dysfunction.

Purpose of the Study:

• To investigate the regulatory role of lpr B cells in the development of autoimmunity.
• To determine if eliminating lpr B cells impacts lymphadenopathy and autoantibody production.
• To assess the capacity of normal B cells to respond to antigens in the presence of lpr T cells.

Main Methods:

• Generation of lpr-+ mixed bone marrow chimeras.
• Selective depletion of lpr B cells using allele-specific monoclonal antibody (mAb) treatment.
• Analysis of lymph node cell counts, T cell populations (CD4-CD8-B220+), autoantibody production, and B cell responses to conventional antigens.

Main Results:

• Mice depleted of lpr B cells showed significantly reduced lymph node cell counts.
• The percentage of abnormal lpr-derived CD4-CD8- T cells was greatly reduced in depleted mice.
• Normal B cells did not produce autoantibodies, and lpr T cells alone could not inhibit normal B cell responses to antigens.

Conclusions:

• B cells play a critical regulatory role in T cell-mediated autoimmunity.
• B cells also regulate the function and responses of other B cells.
• The Fas apoptosis receptor mutation (lpr) impacts B cell regulation, contributing to autoimmune pathogenesis.